Aerovate Newsroom

Oppenheimer Downgrades Aerovate(AVTE.US) to Hold Rating, Cuts Target Price to $3

Futu NewsAug 13 20:33

Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (ORIC), Aerovate Therapeutics (AVTE) and McKesson (MCK)

TipRanksAug 13 20:04

Wells Fargo Downgrades Aerovate Therapeutics to Equal-Weight, Lowers Price Target to $2

BenzingaJun 18 22:29

Aerovate Therapeutics Analyst Ratings

BenzingaJun 18 01:08

Wedbush Downgrades Aerovate Therapeutics to Neutral From Outperform, Adjusts Price Target to $3 From $41

MT NewswiresJun 17 21:36

Aerovate Therapeutics Analyst Ratings

BenzingaJun 6 21:55

Wedbush Reiterates Outperform on Aerovate Therapeutics, Maintains $41 Price Target

BenzingaJun 6 21:55

Jefferies Sticks to Its Buy Rating for Aerovate Therapeutics (AVTE)

TipRanksMay 28 20:15

Aerovate Therapeutics Analyst Ratings

BenzingaMay 22 23:01

Wedbush Reiterates Outperform on Aerovate Therapeutics, Maintains $41 Price Target

BenzingaMay 22 23:00

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Aerovate Therapeutics (AVTE)

TipRanksMay 22 17:55

Wedbush: Reiterates Aerovate Therapeutics (AVTE.US) rating, adjusted from better than market to better than market rating, with a target price of $41.00.

Zhitong FinanceMay 14 20:41

Aerovate Therapeutics Analyst Ratings

BenzingaMay 14 20:35

Wedbush Reiterates Outperform on Aerovate Therapeutics, Maintains $41 Price Target

BenzingaMay 14 20:35

Wedbush Remains a Buy on Aerovate Therapeutics (AVTE)

TipRanksMay 14 20:02

Aerovate Therapeutics Analyst Ratings

BenzingaApr 2 00:10

Wells Fargo Maintains Overweight on Aerovate Therapeutics, Maintains $35 Price Target

BenzingaApr 2 00:10

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)

TipRanksMar 27 18:16

Aerovate Therapeutics Analyst Ratings

BenzingaMar 25 20:40

Jefferies Assumes Aerovate Therapeutics at Buy, Raises Price Target to $65

BenzingaMar 25 20:40